Bioethics News

Counterfeit Alprazolam Poses a ‘Major Public Health Threat’

August 9, 2016

(Medscape) – Counterfeit versions of the benzodiazepine alprazolam (Xanax, Pharmacia and Upjohn) that contain the highly potent opioid fentanyl are being sold online, placing individuals at risk for serious adverse effects and even death, US experts warn. Ann M. Arens, MD, California Poison Control System–San Francisco Division, California, and colleagues report eight cases in which individuals who ingested the tablets, some of which also contained the benzodiazepine etizolam, experienced central nervous system (CNS) depression and cardiovascular effects.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.